CannBioRx Net Debt from 2010 to 2024

ATNFW Stock

USD 0.01 0.0001 1.22%

CannBioRx Life Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt will likely drop to about -967.8 K in 2024. Net Debt is the total debt of CannBioRx Life Sciences minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2017-06-30

Previous Quarter

-704 K

Current Value

278.2 K

Quarterly Volatility

3.1 M

Covid

Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 42.59, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.

Check out the analysis of CannBioRx Life Correlation against competitors.

Latest CannBioRx Life's Net Debt Growth Pattern

Below is the plot of the Net Debt of CannBioRx Life Sciences over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. CannBioRx Life's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CannBioRx Life's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Net Debt

Timeline

CannBioRx Net Debt Regression Statistics

	Arithmetic Mean	(824,474)
	Coefficient Of Variation	(287.71)
	Mean Deviation	1,398,541
	Median	(428,393)
	Standard Deviation	2,372,074
	Sample Variance	5.6T
	Range	9.7M
	R-Value	(0.28)
	Mean Square Error	5.6T
	R-Squared	0.08
	Significance	0.31
	Slope	(149,616)
	Total Sum of Squares	78.8T

CannBioRx Net Debt History

	2024	-967.8 K
	2023	-921.7 K
	2022	-5.6 M
	2021	-6.3 M
	2020	1.7 M
	2019	3.4 M
	2018	-270.9 K

Other Fundumenentals of CannBioRx Life Sciences

Net Debt To E B I T D A

CannBioRx Life Net Debt component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Debt	Short Term Investments	Accounts Payable	Net Receivables	Good Will	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Intangible Assets	Long Term Debt	Current Deferred Revenue
Total Assets		0.43	0.09	0.69	0.44	0.13	0.88	0.85	0.03	-0.08	0.1	0.22	0.24	0.22	0.13	0.34	-0.25	0.24	0.13	0.23
Total Stockholder Equity	0.43		-0.24	0.53	0.91	0.55	0.63	-0.1	-0.05	-0.64	0.03	0.66	0.18	0.14	-0.08	0.62	-0.28	0.23	-0.07	0.16
Retained Earnings	0.09	-0.24		-0.63	-0.42	-0.72	-0.18	0.29	0.39	0.89	0.45	-0.42	0.89	0.92	0.92	0.39	-0.66	0.84	0.95	0.89
Capital Surpluse	0.69	0.53	-0.63		0.65	0.56	0.83	0.42	-0.15	-0.71	-0.17	0.43	-0.44	-0.48	-0.52	-0.04	0.25	-0.41	-0.53	-0.44
Total Liab	0.44	0.91	-0.42	0.65		0.69	0.65	-0.08	-0.16	-0.74	0.11	0.85	0.0	-0.09	-0.24	0.59	-0.26	0.02	-0.26	-0.02
Total Current Assets	0.13	0.55	-0.72	0.56	0.69		0.22	-0.22	-0.77	-0.76	-0.52	0.78	-0.47	-0.45	-0.76	0.22	0.4	-0.3	-0.74	-0.5
Short Term Debt	0.88	0.63	-0.18	0.83	0.65	0.22		0.59	0.22	-0.43	0.25	0.38	0.04	-0.02	0.02	0.24	-0.23	0.03	-0.01	0.04
Common Stock	0.85	-0.1	0.29	0.42	-0.08	-0.22	0.59		0.08	0.32	0.07	-0.2	0.19	0.21	0.23	0.01	-0.11	0.18	0.23	0.2
Net Debt	0.03	-0.05	0.39	-0.15	-0.16	-0.77	0.22	0.08		0.22	0.73	-0.43	0.36	0.26	0.65	-0.1	-0.54	0.15	0.6	0.4
Short Term Investments	-0.08	-0.64	0.89	-0.71	-0.74	-0.76	-0.43	0.32	0.22		0.23	-0.62	0.61	0.66	0.71	0.05	-0.34	0.56	0.73	0.61
Accounts Payable	0.1	0.03	0.45	-0.17	0.11	-0.52	0.25	0.07	0.73	0.23		0.1	0.47	0.36	0.71	0.24	-0.76	0.39	0.67	0.47
Net Receivables	0.22	0.66	-0.42	0.43	0.85	0.78	0.38	-0.2	-0.43	-0.62	0.1		-0.11	-0.16	-0.3	0.51	-0.12	0.04	-0.31	-0.15
Good Will	0.24	0.18	0.89	-0.44	0.0	-0.47	0.04	0.19	0.36	0.61	0.47	-0.11		0.98	0.88	0.73	-0.86	0.9	0.9	1.0
Net Invested Capital	0.22	0.14	0.92	-0.48	-0.09	-0.45	-0.02	0.21	0.26	0.66	0.36	-0.16	0.98		0.85	0.67	-0.74	0.95	0.89	0.96
Short Long Term Debt	0.13	-0.08	0.92	-0.52	-0.24	-0.76	0.02	0.23	0.65	0.71	0.71	-0.3	0.88	0.85		0.4	-0.81	0.78	0.98	0.88
Capital Stock	0.34	0.62	0.39	-0.04	0.59	0.22	0.24	0.01	-0.1	0.05	0.24	0.51	0.73	0.67	0.4		-0.74	0.69	0.41	0.72
Net Working Capital	-0.25	-0.28	-0.66	0.25	-0.26	0.4	-0.23	-0.11	-0.54	-0.34	-0.76	-0.12	-0.86	-0.74	-0.81	-0.74		-0.68	-0.78	-0.87
Intangible Assets	0.24	0.23	0.84	-0.41	0.02	-0.3	0.03	0.18	0.15	0.56	0.39	0.04	0.9	0.95	0.78	0.69	-0.68		0.84	0.87
Long Term Debt	0.13	-0.07	0.95	-0.53	-0.26	-0.74	-0.01	0.23	0.6	0.73	0.67	-0.31	0.9	0.89	0.98	0.41	-0.78	0.84		0.89
Current Deferred Revenue	0.23	0.16	0.89	-0.44	-0.02	-0.5	0.04	0.2	0.4	0.61	0.47	-0.15	1.0	0.96	0.88	0.72	-0.87	0.87	0.89

Click cells to compare fundamentals

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-921.7 K	-967.8 K
Net Debt To EBITDA	0.04	0.04

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CannBioRx Net Debt from 2010 to 2024

Latest CannBioRx Life's Net Debt Growth Pattern

CannBioRx Net Debt Regression Statistics

CannBioRx Net Debt History

Other Fundumenentals of CannBioRx Life Sciences

CannBioRx Life Net Debt component correlations

About CannBioRx Life Financial Statements

Also Currently Popular

Additional Tools for CannBioRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY